Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2023

Genmab — Maj 2023

Planlagt Fastgjort Låst Flyttet Genmab
490 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    JKY_VH
    wrote on sidst redigeret af
    #20

    God morgen, håber solen skinner på dig og markedet i dag bibob;-)

    1 Reply Last reply
    0
    • A Offline
      A Offline
      AaBforever
      wrote on sidst redigeret af
      #21

      Det går da meget godt i dag....minus Genmab.

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #22

        JKY. 08.20. Tak for det. 26 ˚ kl 09.00 er vel ok. 🙂 håber også markedet stiger i graderne i dag. 😉

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #23

          new trial by the University of Birmingham (Genmab collaborates) in Relapsed Follicular Lymphoma, containing Epcoritamab + lenalidomide. Interesting how 2 of the experimental arms will open only in 2025 and 2027 with drugs still to be announced. https://clinicaltrials.gov/ct2/show/NCT05848765

          1 Reply Last reply
          0
          • J Offline
            J Offline
            JKY_VH
            wrote on sidst redigeret af
            #24

            Lyder dejligt bibob. Solen skinner også her og OMX +1,85%. Desværre kunne Genmab ikke følge helt med, men 0,59% har også ret;-)

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #25

              Biontech conf call https://www.fool.com/earnings/call-transcripts/2023/05/08/biontech-se-bntx-q1-2023-earnings-call-transcript/ "in principle, FixVac could be an option for patients with advanced metastatic disease. But again, here, it's a question of the combination compounds. And this is something that is now in the focus of our upcoming studies evaluating the use of these vaccines in combination with our checkpoint immunomodulators, for example, the bispecific BNT312 and BNT311 molecules,
              "

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #26

                https://labuonasalute.it/2023/05/08/tumori-del-sangue-3.html teclistamab in Italie now

                1 Reply Last reply
                0
                • troldmandenT Offline
                  troldmandenT Offline
                  troldmanden
                  wrote on sidst redigeret af
                  #27

                  Ofte ser man biotech aktier stige frem mod mulig godkendelse. Genmab går i den anden retning. Nogen der ved om der er analytikere der hælder til et nej i denne omgang?

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #28

                    Ja lidt underligt at der er nedtur frem mod regnskab i morgen og PDUFA date for epco

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #29

                      Godt nok under lav omsætning

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #30

                        Nogen der ved om FDA holder deres tidslinjer pt?

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #31

                          small new trial: Daratumumab in Acquired Hemophilia A https://clinicaltrials.gov/ct2/show/NCT05849740

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #32

                            and another one: Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma https://clinicaltrials.gov/ct2/show/NCT05849610

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #33

                              Spotlight On: Chris Cozic, Executive Vice President & Chief People Officer, Genmab https://www.capitalanalyticsassociates.com/spotlight-on-chris-cozic-executive-vice-president-chief-people-officer-genmab/

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #34

                                Godmorgen 🙂

                                1 Reply Last reply
                                0
                                • D Offline
                                  D Offline
                                  Doublo
                                  wrote on sidst redigeret af
                                  #35

                                  God morgen vi krydser fingre fo ret godt regnskab og gode nyheder.

                                  1 Reply Last reply
                                  0
                                  • T Offline
                                    T Offline
                                    Teller
                                    wrote on sidst redigeret af
                                    #36

                                    Jeg har på fornemmelsen der kommer godt nyt 🙂

                                    1 Reply Last reply
                                    0
                                    • nohopeN Offline
                                      nohopeN Offline
                                      nohope
                                      wrote on sidst redigeret af
                                      #37

                                      Er der et klokkeslet ?

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #38

                                        plejer det ikke at være umiddelbart efter lukketid på børsen?

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gdn55
                                          wrote on sidst redigeret af
                                          #39

                                          Jo

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper